title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma  ( GBM )  and Diffuse Intrinsic Pontine Glioma  ( DIPG )  at White House - Chimerix  ( NASDAQ:CMRX ) ,20230525T110000,https://www.benzinga.com/pressreleases/23/05/g32569879/chimerix-to-participate-in-cancer-moonshot-brain-cancers-forum-on-glioblastoma-gbm-and-diffuse-int,NHPEF,0.092213,Somewhat-Bullish,0.162349
Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma  ( GBM )  and Diffuse Intrinsic Pontine Glioma  ( DIPG )  at White House,20230525T110000,https://www.globenewswire.com/news-release/2023/05/25/2675974/25619/en/Chimerix-to-Participate-in-Cancer-Moonshot-Brain-Cancers-Forum-on-Glioblastoma-GBM-and-Diffuse-Intrinsic-Pontine-Glioma-DIPG-at-White-House.html,NHPEF,0.097062,Somewhat-Bullish,0.164725
uniQure announces positive CHMP opinion for etranacogene dezaparvovec - gene therapy for adults with hemophilia B,20221216T121500,https://www.globenewswire.com/news-release/2022/12/16/2575374/0/en/uniQure-announces-positive-CHMP-opinion-for-etranacogene-dezaparvovec-gene-therapy-for-adults-with-hemophilia-B.html,NHPEF,0.027892,Neutral,0.0
"Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer",20231002T120000,https://www.prnewswire.com/news-releases/aadi-bioscience-appoints-dave-lennon-phd-as-president-and-chief-executive-officer-301944034.html,NHPEF,0.031949,Neutral,0.087731
"MRNA: Which of These 3 Biotech Stocks Are a Buy, Sell, or Hold?",20230901T174349,https://stocknews.com/news/mrna-fold-mgnx-mrk-incy-which-of-these-3-biotech-stocks-are-a-buy-sell/,NHPEF,0.02922,Neutral,0.097347
"Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center - Clearmind Medicine  ( NASDAQ:CMND ) ",20240201T131500,https://www.benzinga.com/pressreleases/24/02/g36887068/clearmind-medicine-announces-exclusive-long-term-licensing-agreement-with-leading-israeli-research,NHPEF,0.072,Neutral,0.065006
"Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center",20240201T131500,https://www.globenewswire.com/news-release/2024/02/01/2821963/0/en/Clearmind-Medicine-Announces-Exclusive-Long-Term-Licensing-Agreement-with-Leading-Israeli-Research-Center.html,NHPEF,0.073209,Neutral,0.064122
Clearmind Medicine Completed Type A Meeting with the FDA,20240110T121800,https://www.globenewswire.com/news-release/2024/01/10/2806995/0/en/Clearmind-Medicine-Completed-Type-A-Meeting-with-the-FDA.html,NHPEF,0.100308,Neutral,0.030541
Clearmind Medicine Achieved Positive Results in Cocaine Addiction Treatment,20231205T134700,https://www.globenewswire.com/news-release/2023/12/05/2790952/0/en/Clearmind-Medicine-Achieved-Positive-Results-in-Cocaine-Addiction-Treatment.html,NHPEF,0.087663,Neutral,0.023248
"The Immunotherapy Market Is Expected to Surpass $351.56 Billion By 2030 - Creative Medical Technology Holdings, Inc.  ( NASDAQ: CELZ )  Is Contributing to This Growth - Coya Therapeutics  ( NASDAQ:COYA ) , Creative Medical Tech  ( NASDAQ:CELZ ) ",20230712T122126,https://www.benzinga.com/general/biotech/23/07/33197087/the-immunotherapy-market-is-expected-to-surpass-351-56-billion-by-2030-creative-medical-technolog,NHPEF,0.085936,Somewhat-Bullish,0.289581
